These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2530767)
1. An interim overview of the safety and tolerability of paroxetine. Dunbar GC Acta Psychiatr Scand Suppl; 1989; 350():135-7. PubMed ID: 2530767 [No Abstract] [Full Text] [Related]
2. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline. Kuhs H; Rudolf GA Acta Psychiatr Scand Suppl; 1989; 350():145-6. PubMed ID: 2530773 [No Abstract] [Full Text] [Related]
3. Antidepressants and the peripheral nervous system. Husstedt IW; Kuhs H; Rudolf GA; Brune GG Acta Psychiatr Scand Suppl; 1989; 350():147-8. PubMed ID: 2530774 [No Abstract] [Full Text] [Related]
5. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic. Miller SM; Naylor GJ; Murtagh M; Winslow G Acta Psychiatr Scand Suppl; 1989; 350():143-4. PubMed ID: 2530772 [No Abstract] [Full Text] [Related]
6. Paroxetine plasma levels: lack of correlation with efficacy or adverse events. Tasker TC; Kaye CM; Zussman BD; Link CG Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776 [No Abstract] [Full Text] [Related]
7. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766 [No Abstract] [Full Text] [Related]
8. A comparison of paroxetine, imipramine and placebo in depressed out-patients. Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664 [TBL] [Abstract][Full Text] [Related]
10. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382 [TBL] [Abstract][Full Text] [Related]
11. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements. Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251 [TBL] [Abstract][Full Text] [Related]
12. The clinical pharmacology of paroxetine in healthy subjects. Raptopoulos P; McClelland GR; Jackson D Acta Psychiatr Scand Suppl; 1989; 350():46-8. PubMed ID: 2530788 [No Abstract] [Full Text] [Related]
13. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients. Bascara L Acta Psychiatr Scand Suppl; 1989; 350():141-2. PubMed ID: 2530771 [No Abstract] [Full Text] [Related]
15. The effect of paroxetine on the quantitative EEG. McClelland GR; Raptopoulos P; Jackson D Acta Psychiatr Scand Suppl; 1989; 350():50-2. PubMed ID: 2530790 [No Abstract] [Full Text] [Related]
16. The pharmacokinetics of paroxetine in renal impairment. Doyle GD; Laher M; Kelly JG; Byrne MM; Clarkson A; Zussman BD Acta Psychiatr Scand Suppl; 1989; 350():89-90. PubMed ID: 2530798 [No Abstract] [Full Text] [Related]
17. The pharmacokinetics of paroxetine in elderly depressed patients. Ghose K Acta Psychiatr Scand Suppl; 1989; 350():87-8. PubMed ID: 2530797 [No Abstract] [Full Text] [Related]
18. A double-blind, multicentre study of paroxetine and mianserin in depression. Mertens C; Pintens H Acta Psychiatr Scand Suppl; 1989; 350():140. PubMed ID: 2530770 [No Abstract] [Full Text] [Related]
19. The effect of paroxetine on the electroencephalogram, electrocardiogram, and blood pressure. Edwards JG; Goldie A; Papayanni-Papasthatis S; Punter J; Sedgwick EM Acta Psychiatr Scand Suppl; 1989; 350():124. PubMed ID: 2530762 [No Abstract] [Full Text] [Related]
20. Absorption of paroxetine under various dietary conditions and following antacid intake. Greb WH; Brett MA; Buscher G; Dierdorf HD; von Schrader HW; Wolf D; Mellows G; Zussman BD Acta Psychiatr Scand Suppl; 1989; 350():99-101. PubMed ID: 2530802 [No Abstract] [Full Text] [Related] [Next] [New Search]